Immediate Impact
6 standout
Citing Papers
The two sides of chromosomal instability: drivers and brakes in cancer
2024 Standout
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
2020 Standout
Works of Ravit Geva being referenced
Phase 1 first-in-human trial of MTB-9655, the first oral inhibitor of ACSS2, in patients with advanced solid tumors.
2022
KEYNOTE-164: Phase 2 study of pembrolizumab for patients with previously treated, microsatellite instability-high advanced colorectal carcinoma.
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ravit Geva | 23 | 12 | 8 | 4 | 33 | |
| Alla Karpova | 23 | 10 | 10 | 4 | 40 | |
| Yulong Zong | 12 | 9 | 10 | 4 | 42 | |
| Martin Hogg | 20 | 9 | 5 | 2 | 31 | |
| Paweł Bury | 19 | 12 | 5 | 6 | 33 | |
| Hwoei Fen Soo Hoo | 25 | 8 | 6 | 4 | 35 | |
| M.M. Jimenez | 29 | 11 | 3 | 6 | 35 | |
| Jaya Thomas | 17 | 14 | 9 | 6 | 30 | |
| Anna Berthel | 39 | 29 | 8 | 2 | 48 | |
| Marta Casarrubios | 27 | 14 | 15 | 5 | 42 | |
| Abraham Tzou | 13 | 6 | 5 | 2 | 25 |
All Works
Loading papers...